Please login to the form below

Not currently logged in
Email:
Password:

Sanofi Pasteur and Vivalis collaboration

Sanofi Pasteur has announced its partnership with Vivalis for the discovery and development of antibody treatments

Sanofi Pasteur, the vaccines division of sanofi-aventis (S-A), has announced its partnership with biopharmaceutical company, Vivalis, for the discovery and development of antibody treatments.

The collaboration will see Sanofi Pasteur acquire exclusive access to Vivalis' Humalex platform – a range of technologies for the discovery of fully human monoclonal antibodies targeting clinically significant infectious diseases.

Monoclonal antibodies are used in therapies to bind to specific target cells to stimulate the patient's immune system to attack the cells.

Sanofi Pasteur will also gain worldwide exclusive development and commercialisation rights for the discovered antibodies.

In return, Vivalis will receive an upfront payment of €3m, with potential milestone payments of up to €35m for each infectious disease therapy over the course of the development stage. The company will also receive royalty payments from future product sales.

"We are pleased to team up with Vivalis to discover and develop new biologicals against infectious diseases for patients worldwide," said Michel de Wilde, senior vice president, Research and Development, Sanofi Pasteur.

"Vivalis' Humalex technology allows rapid identification of clinically relevant fully human antibodies, as well as their related antigen. This opens up new medical solutions to prevent or treat serious infections."

Franck Grimaud, CEO of Vivalis, said: "This is the first major commercial agreement on the Humalex platform but it also represents a strong validation of the technology. Vivalis is today one of a very few companies able to propose a fully integrated offering from the discovery of fully human monoclonal antibodies to the production of clinical batches."

8th June 2010

Share

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Graphite Digital

Graphite is a digital agency which partners with globally respected pharma and healthcare organisations to create powerful digital experiences. We...

Latest intelligence

#DemandDiversity: For International Women's Day, we ask... why do women often suffer from more side effects than men?
Women are largely prescribed exactly the same treatment regimens as men, with no account for the underlying differences in physiology and drug metabolism between the sexes....
Good design saves lives
Good design and creative thinking are essential if we are to improve on existing problems in new ways, which is why design and creativity within healthcare is vital. Health is...
Why you must understand the pricing of patient recruitment companies
Recruiting a diverse range of patients and engaging with them for your clinical trial isn’t an easy task, which means you might turn to patient recruitment companies, like us, who...

Infographics